Click here for printer-friendly version
- Fourth quarter 2007 diluted earnings per share increased by 18.0% to $1.51 - Medical enrollment grew by 708,000 members during 2007 - Selling, general and administrative expense ratio continued to improve, declining by 120 basis points during the year - Operating cash flow exceeded $4.3 billion for the year, or 1.3 times net income - Company reiterates diluted earnings per share target of $6.41 for 2008, representing growth of 15.3% over 2007INDIANAPOLIS, Jan 23, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- WellPoint, Inc.
(NYSE: WLP) today announced that fourth quarter 2007 net income was $859.1
million, or $1.51 per share, which included net realized investment gains of
less than $0.01 per share. Net income in the fourth quarter of 2006 was
$801.1 million, or $1.28 per share, which included net realized investment
gains of $0.01 per share. Full year 2007 net income was $5.56 per share,
which included $0.01 per share in net realized investment gains. Net income
for full year 2006 was $4.82 per share, which included tax benefits of $0.04
per share due to a change in the Company's state tax apportionment factors.
"We are pleased that WellPoint achieved its earnings per share
expectations during 2007 and continued its strong organic membership growth.
We view this as an excellent indication that customers continue to find great
value in the products and services we are providing to the marketplace," said
Angela F. Braly, president and chief executive officer of WellPoint, Inc. "As
we continue to grow, we are also operating more efficiently each year. During
2007, we were able to reduce our general and administrative costs by more than
$175 million while servicing 708,000 new medical members."
"We remain confident in our earnings per share target of $6.41 for 2008,
which represents annual growth of 15.3 percent," said Wayne S. DeVeydt, chief
financial officer of WellPoint, Inc. "We expect to continue generating strong
cash flow in excess of our net income, and we plan to utilize our capital to
expand product offerings, enhance services and improve returns for our
shareholders. We expect to repurchase more than $4.0 billion of our stock
during 2008, subject to market conditions."
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled 34.8 million members at December
31, 2007, an increase of 708,000 members from 34.1 million at December 31,
2006. The largest enrollment increase was realized in the National business,
which grew by 537,000 members. Large, multi-state organizations continue to
be attracted to WellPoint's compelling value proposition, which includes
access to the broadest provider network in the industry, competitive pricing,
leading wellness and care management programs, and innovative products and
services.
Membership in State Sponsored business increased by 292,000 during 2007,
as the Company entered new markets with its Medicaid managed care programs.
The Company also expanded geographically in the Senior business, adding 57,000
members, and enrollment in the Federal Employee Program ("FEP") increased by
23,000. Membership declined by 201,000 members in the Local Group and
Individual businesses, collectively, during 2007. Approximately 90 percent of
these enrollment declines occurred in the Company's non-Blue branded service
areas.
During the fourth quarter of 2007, the state of Connecticut implemented
changes to its Medicaid managed care programs which resulted in approximately
144,000 members converting from fully insured to self-funded contractual
arrangements. The Company is currently servicing these members under a self-
funded arrangement that expires on February 29, 2008, unless extended.
In January 2008, the Company provided notice to the state of Ohio that it
will terminate participation in the Ohio Covered Families & Children's ("CFC")
Medicaid program by March 31, 2008. The Company was unable to reach an
agreement with the state that would allow the Company to continue
participating in this program in a financially-responsible manner. This
action is expected to result in a membership reduction of approximately
145,000 during the first quarter of 2008.
The Company will continue to serve approximately 21,000 Aged, Blind and
Disabled beneficiaries in the state of Ohio and remains committed to
partnering with governments across the nation to manage state-sponsored
programs in a responsible manner. The Company continues to provide services
to more than 2.0 million such members in 14 states and is expanding its
programs to South Carolina in 2008.
Operating Revenue: Operating revenue was $15.3 billion in the fourth
quarter of 2007, an increase of 6.8 percent from $14.3 billion in the prior
year fourth quarter. For full year 2007, operating revenues reached $60.1
billion, an increase of 7.1 percent over 2006. The revenue increases were
driven by disciplined pricing in the Local Group business and growth in State
Sponsored and Medicare Advantage membership.
Benefit Expense Ratio: The benefit expense ratio was 82.9 percent in the
fourth quarter of 2007, an increase of 190 basis points from 81.0 percent in
the prior year quarter. Approximately 110 basis points of this increase
related to the timing of prior period development in the Company's Commercial
and Consumer Business ("CCB") segment. Comparison to the fourth quarter of
2006 was unfavorably impacted by fourth quarter 2006 medical claims
liabilities in CCB that developed less favorably in 2007 than expected. The
CCB segment also experienced a relatively high level of intra-year reserve
adjustments during the fourth quarter of 2007.
Higher-than-anticipated medical claims in the Company's Ohio and
Connecticut State Sponsored operations also impacted the Company's fourth
quarter 2007 benefit expense ratio. The Company is currently in the process
of exiting the Ohio CFC Medicaid program due to the inability to obtain
fiscally-sound rates. The Connecticut Medicaid contract converted to a self-
funded arrangement during the fourth quarter of 2007. The Company incurred
operating losses in both of these programs during 2007.
The full year 2007 benefit expense ratio was 82.4 percent, an increase of
120 basis points from 81.2 percent in 2006. Approximately 80 basis points of
the increase was driven by the medical business of the Specialty, Senior and
State Sponsored Business reporting segment. The remaining increase was
attributed to the CCB segment and included the impact of business mix shifts,
including a decline in Individual membership, and less favorable than expected
reserve development in 2007.
The Company remains confident with its full year 2008 benefit expense
ratio estimate of 81.6 percent, given the strong full year 2007 operating
results in its CCB segment, its outlook for stable medical cost trends in 2008
and the expected improvements in its State Sponsored operations.
Premium and Cost Trends: Trends include Local Group and Individual fully-
insured businesses.
Medical cost trends were below 8.0 percent in 2007, with the primary
driver being unit cost increases. The Company continues to expect that
medical cost trends will remain below 8.0 percent in 2008, and continues to
price its business so that expected premium yield exceeds total cost trend,
where total cost trend includes medical costs and selling, general and
administrative ("SG&A") expense.
SG&A Expense Ratio: The SG&A expense ratio was 13.8 percent in the fourth
quarter of 2007, a decrease of 190 basis points from 15.7 percent in the
fourth quarter of 2006. For the full year of 2007, the SG&A expense ratio was
14.5 percent, a decline of 120 basis points from 15.7 percent in 2006. The
ratio improved year-over-year due to a continued focus on optimizing
administrative costs and spreading expenses across a growing revenue base.
The Company continues to realize savings from reorganization efforts and
capitalize on employee productivity improvements.
Operating Cash Flow: For the full year 2007, operating cash flow exceeded
$4.3 billion, or 1.3 times net income. Operating cash flow totaled $1.1
billion in the fourth quarter of 2007, or 1.3 times net income.
Days in Claims Payable: Days in claims payable as of December 31, 2007,
was 45.0 days, a decrease of 1.8 days from 46.8 days as of September 30, 2007.
The decline was primarily due to the timing of claims payments and a reduction
in the claims turnaround cycle.
Share Repurchase Program: During the fourth quarter of 2007, the Company
repurchased 22.5 million shares of its common stock for $1.8 billion. For the
full year of 2007, the Company repurchased 76.9 million shares of its stock
for $6.2 billion. At December 31, 2007, cash and investments held at the
parent company and available for general corporate use totaled $2.2 billion.
REPORTABLE SEGMENTS
In 2007, WellPoint, Inc. had the following reportable segments: Commercial
and Consumer Business ("CCB"), Specialty, Senior, and State Sponsored Business
("4SB"), and Other, which included FEP business, National Government Services,
Inc., intersegment sales and expense eliminations, and corporate expenses not
allocated to the other reportable segments.
Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment.
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
(In millions) Three Months Ended December 31
2007 2006 Change
Operating Revenue
CCB $10,627.2 $10,321.7 3.0%
4SB 3,601.6 3,015.4 19.4%
Other:
External Customers 1,564.0 1,387.9 12.7%
Intersegment Eliminations (475.4) (381.6) (24.6%)
Other 1,088.6 1,006.3 8.2%
Total Operating Revenue 15,317.4 14,343.4 6.8%
Operating Gain (Loss)
CCB $872.0 $854.7 2.0%
4SB 392.3 379.7 3.3%
Other 15.0 (12.7) -
Operating Margin
CCB 8.2% 8.3% (10) bp
4SB 10.9% 12.6% (170) bp
(In millions) Year Ended December 31
2007 2006 Change
Operating Revenue
CCB $42,122.0 $40,602.6 3.7%
4SB 13,715.4 11,553.1 18.7%
Other:
External Customers 5,985.2 5,441.8 10.0%
Intersegment Eliminations (1,700.6) (1,437.1) (18.3%)
Other 4,284.6 4,004.7 7.0%
Total Operating Revenue 60,122.0 56,160.4 7.1%
Operating Gain (Loss)
CCB $3,999.7 $3,679.5 8.7%
4SB 972.3 1,117.0 (13.0%)
Other 12.2 (59.6) -
Operating Margin
CCB 9.5% 9.1% 40 bp
4SB 7.1% 9.7% (260) bp
Commercial and Consumer Business: Operating gain for the CCB segment was
$872.0 million in the fourth quarter of 2007, an increase of 2.0 percent
compared with $854.7 million in the fourth quarter of 2006. The year-over-
year growth in operating gain was driven by revenue growth and lower SG&A
costs, partially offset by higher benefit expense due to the timing of prior
period reserve development in 2006 and 2007, as described in the "Benefit
Expense Ratio" section.
For full year 2007, operating gain was $4.0 billion, an increase of 8.7
percent over 2006. The increase in operating gain was driven by premium rate
increases across all lines of business and lower general and administrative
expenses, partially offset by an increase in the segment's benefit expense
ratio. Operating margin in the CCB segment expanded by 40 basis points during
2007, confirming the Company's disciplined commercial pricing.
Specialty, Senior, and State Sponsored Business: Operating gain for the
4SB segment totaled $392.3 million in the fourth quarter of 2007, an increase
of 3.3 percent compared with $379.7 million in the fourth quarter of 2006.
The increase in operating gain was driven by lower performance-based incentive
compensation in 2007 and improved results in the Company's Pharmacy Benefit
Management ("PBM") mail-order business, partially offset by lower Medicare
Supplement and State Sponsored Business profitability.
Operating gain totaled $972.3 million for the full year of 2007, a
decrease of 13.0 percent from $1.1 billion in 2006. Deterioration in the
financial performance of the Company's State Sponsored operations and lower
Medicare Supplement profitability was partially offset by growth in the PBM
business.
Other: Operating gain for the Other segment totaled $15.0 million in the
fourth quarter of 2007, which compares to an operating loss of $12.7 million
in the fourth quarter of 2006. For full year 2007, operating gain was $12.2
million, compared with an operating loss of $59.6 million in 2006. Results in
this segment improved year-over-year due to the non-recurrence of merger-
related retention bonuses and growth in the FEP.
OUTLOOK
Full Year 2008:
- The Company continues to expect net income of $6.41 per share,
representing growth of 15.3% over 2007.
- Year-end medical enrollment is now expected to be approximately 35.6
million members, representing growth for the year of approximately
800,000 members.
- Operating revenue is now expected to total approximately $62.6
billion.
- The benefit expense ratio is expected to be approximately 81.6
percent.
- The SG&A expense ratio is expected to be approximately 14.4 percent.
- The Company continues to expect operating cash flow of $4.4 billion,
or 1.2 times net income.
Basis of Presentation
- Operating gain is defined as operating revenue less benefit expense,
selling expense, general and administrative expense, and cost of drugs.
Operating gain is used to analyze profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
- Operating margin is defined as operating gain divided by operating
revenue.
- Certain prior period amounts have been reclassified to conform to
current period presentation.
- The Company expects to revise its reportable segments in the first
quarter of 2008 in accordance with its new organizational structure,
which reflects how management makes business decisions beginning
January 1, 2008.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Standard Time ("EST") to discuss its fourth quarter earnings results
and updated outlook. The conference call should be accessed at least 15
minutes prior to the start of the call with the following numbers:
888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)
651-291-5254 (International) 320-365-3844 (International Replay)
An access code is not required for today's conference call. The access
code for the replay is 857272. The replay will be available from 1:45 p.m.
EST today until the end of the day on February 6, 2008. The call will also be
available through a live webcast at www.wellpoint.com under "Investor Info."
A webcast replay will be available following the call.
About WellPoint, Inc.
WellPoint's mission is to improve the lives of the people it serves and
the health of its communities. WellPoint, Inc. is the largest health benefits
company in terms of commercial membership in the United States. Through its
nationwide networks, the company delivers a number of leading health benefit
solutions through a broad portfolio of integrated health care plans and
related services, along with a wide range of specialty products such as life
and disability insurance benefits, pharmacy benefit management, dental,
vision, behavioral health benefit services, as well as long term care
insurance and flexible spending accounts. Headquartered in Indianapolis,
Indiana, WellPoint is an independent licensee of the Blue Cross and Blue
Shield Association and serves its members as the Blue Cross licensee for
California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut,
Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the
Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield
in 10 New York City metropolitan and surrounding counties and as Blue Cross or
Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia
(excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and
through UniCare. Additional information about WellPoint is available at
www.wellpoint.com.
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary
(Unaudited and in Thousands)
Change from
Dec. Dec. Sept. Dec. Sept.
31, 31, 30, 31, 30,
2007 2006 2007 2006 2007
Medical Membership
Customer Type
Local Group 16,663 16,766 16,649 (0.6%) 0.1%
Individual 2,390 2,488 2,432 (3.9%) (1.7%)
National Accounts 6,389 6,136 6,388 4.1% 0.0%
BlueCard 4,563 4,279 4,562 6.6% 0.0%
Total National 10,952 10,415 10,950 5.2% 0.0%
Senior 1,250 1,193 1,250 4.8% 0.0%
State Sponsored 2,174 1,882 2,141 15.5% 1.5%
FEP 1,380 1,357 1,383 1.7% (0.2%)
Total 34,809 34,101 34,805 2.1% 0.0%
Funding Arrangement
Self-Funded 17,737 16,745 17,571 5.9% 0.9%
Fully-Insured 17,072 17,356 17,234 (1.6%) (0.9%)
Total 34,809 34,101 34,805 2.1% 0.0%
Reportable Segment
Commercial & Consumer Business 30,005 29,669 30,031 1.1% (0.1%)
Specialty, Senior & State Sponsored 3,424 3,075 3,391 11.3% 1.0%
Other 1,380 1,357 1,383 1.7% (0.2%)
Total 34,809 34,101 34,805 2.1% 0.0%
Specialty Metrics
PBM Prescription Volume (1) 98,605 95,685 93,694 3.1% 5.2%
Behavioral Health Membership 20,230 16,937 20,168 19.4% 0.3%
Life and Disability Membership 5,598 5,970 5,665 (6.2%) (1.2%)
Dental Membership 5,014 5,270 5,008 (4.9%) 0.1%
Vision Membership 2,401 1,536 2,367 56.3% 1.4%
Medicare Part D Membership (2) 1,614 1,568 1,596 2.9% 1.1%
(1)Represents quarterly prescription volume at the Company's PBM
operation.
(2)Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
and external PBM members with the prescription drug plan benefit.
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
(In millions, except per share data)
Three Months Ended
December 31
2007 2006 Change
Revenues
Premiums $14,266.1 $13,293.9 7.3%
Administrative fees 914.3 905.0 1.0%
Other revenue 137.0 144.5 (5.2%)
Total operating revenue 15,317.4 14,343.4 6.8%
Net investment income 243.4 225.3 8.0%
Net realized gains on investments 0.6 11.1 (94.6%)
Total revenues 15,561.4 14,579.8 6.7%
Expenses
Benefit expense 11,821.7 10,766.7 9.8%
Selling, general and administrative
expense
Selling expense 433.4 424.2 2.2%
General and administrative
expense 1,686.3 1,830.1 (7.9%)
Total selling, general and
administrative expense 2,119.7 2,254.3 (6.0%)
Cost of drugs 96.7 100.7 (4.0%)
Interest expense 125.3 100.0 25.3%
Amortization of other intangible
assets 75.2 74.3 1.2%
Total expenses 14,238.6 13,296.0 7.1%
Income before income tax expense 1,322.8 1,283.8 3.0%
Income tax expense 463.7 482.7 (3.9%)
Net income $859.1 $801.1 7.2%
Net income per diluted share $1.51 $1.28 18.0%
Diluted shares 570.6 627.0 (9.0%)
Benefit expense as a percentage of
premiums 82.9% 81.0% 190 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 13.8% 15.7% (190) bp
Income before income tax expense as a
percentage of total revenues 8.5% 8.8% (30) bp
WellPoint, Inc.
Consolidated Statements of Income
(In millions, except per share data)
Year Ended
December 31
2007 2006 Change
(Unaudited)
Revenues
Premiums $55,865.0 $51,971.9 7.5%
Administrative fees 3,674.6 3,595.4 2.2%
Other revenue 582.4 593.1 (1.8%)
Total operating revenue 60,122.0 56,160.4 7.1%
Net investment income 1,001.1 878.7 13.9%
Net realized gains (losses) on
investments 11.2 (0.3) -
Total revenues 61,134.3 57,038.8 7.2%
Expenses
Benefit expense 46,036.1 42,191.4 9.1%
Selling, general and administrative
expense
Selling expense 1,716.8 1,654.5 3.8%
General and administrative
expense 6,984.7 7,163.2 (2.5%)
Total selling, general and
administrative expense 8,701.5 8,817.7 (1.3%)
Cost of drugs 400.2 414.4 (3.4%)
Interest expense 447.9 403.5 11.0%
Amortization of other intangible
assets 290.7 297.4 (2.3%)
Total expenses 55,876.4 52,124.4 7.2%
Income before income tax expense 5,257.9 4,914.4 7.0%
Income tax expense 1,912.5 1,819.5 5.1%
Net income $3,345.4 $3,094.9 8.1%
Net income per diluted share $5.56 $4.82 15.4%
Diluted shares 602.0 642.1 (6.2%)
Benefit expense as a percentage of
premiums 82.4% 81.2% 120 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 14.5% 15.7% (120) bp
Income before income tax expense as a
percentage of total revenues 8.6% 8.6% 0 bp
WellPoint, Inc.
Consolidated Balance Sheets
(In millions)
December 31, December 31,
2007 2006
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $2,767.9 $2,602.1
Investments available-for-sale, at
fair value 3,766.6 2,522.7
Accrued investment income 165.8 157.2
Premium and self-funded
receivables 2,870.1 2,335.3
Other receivables 996.4 1,172.7
Income taxes receivable 0.9 -
Securities lending collateral 854.1 904.7
Deferred tax assets, net 559.6 642.6
Other current assets 1,050.4 1,284.5
Total current assets 13,031.8 11,621.8
Long-term investments available-for-
sale, at fair value 14,715.3 15,687.4
Property and equipment, net 995.9 988.6
Goodwill 13,435.4 13,383.5
Other intangible assets 9,220.8 9,396.2
Other noncurrent assets 660.8 497.4
Total assets $52,060.0 $51,574.9
Liabilities and shareholders' equity
Liabilities
Current liabilities:
Policy liabilities:
Medical claims payable $5,788.0 $5,290.3
Reserves for future policy
benefits 63.7 76.3
Other policyholder liabilities 1,832.2 2,055.7
Total policy liabilities 7,683.9 7,422.3
Unearned income 1,114.6 987.9
Accounts payable and accrued
expenses 2,909.6 3,242.2
Income taxes payable - 538.2
Security trades pending payable 50.6 124.8
Securities lending payable 854.1 904.7
Current portion of long-term debt 20.4 521.0
Other current liabilities 1,755.0 1,397.4
Total current liabilities 14,388.2 15,138.5
Long-term debt, less current portion 9,023.5 6,493.2
Reserves for future policy benefits,
noncurrent 661.9 646.9
Deferred tax liability, net 3,004.4 3,350.2
Other noncurrent liabilities 1,991.6 1,370.3
Total liabilities 29,069.6 26,999.1
Shareholders' equity
Common stock 5.6 6.1
Additional paid-in capital 18,441.1 19,863.5
Retained earnings 4,387.6 4,656.1
Accumulated other comprehensive
income 156.1 50.1
Total shareholders' equity 22,990.4 24,575.8
Total liabilities and shareholders'
equity $52,060.0 $51,574.9
WellPoint, Inc.
Consolidated Statements of Cash Flows
(In millions)
Year Ended December 31
2007 2006
(Unaudited)
Operating activities
Net income $3,345.4 $3,094.9
Adjustments to reconcile net income
to net cash provided by operating
activities:
Net realized (gains) losses
on investments (11.2) 0.3
Loss on disposal of assets 11.3 1.7
Deferred income taxes (105.5) 273.7
Amortization, net of accretion 466.0 471.9
Depreciation expense 120.2 133.0
Share-based compensation 177.1 246.9
Excess tax benefits from
share-based compensation (153.3) (136.5)
Changes in operating assets and
liabilities, net of effect of
business combinations:
Receivables, net (448.6) (627.8)
Other invested assets, current 26.9 234.9
Other assets 174.4 (362.4)
Policy liabilities 257.7 852.6
Unearned income 125.5 (69.5)
Accounts payable and accrued expenses (235.2) (91.7)
Other liabilities 176.5 134.2
Income taxes 447.3 (112.0)
Other, net (29.9) -
Net cash provided by operating
activities 4,344.6 4,044.2
Investing activities
Purchases of fixed maturity
securities (8,512.0) (11,198.0)
Proceeds from sales and maturities of
fixed maturity securities 7,494.2 10,351.7
Purchase of equity securities (1,389.2) (2,434.5)
Proceeds from sales of equity
securities 2,244.9 2,950.9
Changes in securities lending
collateral 50.6 485.2
Purchases of subsidiaries, net of
cash acquired (298.5) (25.4)
Purchases of property and equipment (322.0) (193.9)
Proceeds from sales of property and
equipment 57.3 6.4
Other, net (94.2) (399.7)
Net cash used in investing activities (768.9) (457.3)
Financing activities
Net (repayments of) proceeds from
commercial paper borrowings 502.8 (306.0)
Proceeds from long-term borrowings 1,978.3 2,668.2
Repayment of long-term borrowings (509.7) (2,162.1)
Changes in securities lending payable (50.6) (485.2)
Changes in bank overdrafts (117.1) 414.3
Repurchase and retirement of common
stock (6,151.4) (4,550.2)
Proceeds from exercise of employee
stock options and employee stock purchase
plan 784.5 559.5
Excess tax benefits from share-based
compensation 153.3 136.5
Net cash used in financing activities (3,409.9) (3,725.0)
Change in cash and cash equivalents 165.8 (138.1)
Cash and cash equivalents at
beginning of year 2,602.1 2,740.2
Cash and cash equivalents at end of
year $2,767.9 $2,602.1
WellPoint, Inc.
Reconciliation of Medical Claims Payable
(In millions)
Years Ended December 31
2007 2006 2005
(Unaudited)
Gross medical claims payable,
beginning of period $5,290.3 $4,853.4 $4,134.0
Ceded medical claims payable,
beginning of period (51.0) (27.7) (31.9)
Net medical claims payable,
beginning of period 5,239.3 4,825.7 4,102.1
Business combinations and purchase
adjustments 15.2 (6.4) 784.5
Net incurred medical claims:
Current year 46,366.2 42,613.2 32,865.6
Prior years (redundancies) (1) (332.7) (617.7) (644.9)
Total net incurred medical claims 46,033.5 41,995.5 32,220.7
Net payments attributable to:
Current year medical claims 40,765.7 37,486.0 28,997.1
Prior years medical claims 4,795.0 4,089.5 3,284.5
Total net payments 45,560.7 41,575.5 32,281.6
Net medical claims payable, end of
period 5,727.3 5,239.3 4,825.7
Ceded medical claims, end of period 60.7 51.0 27.7
Gross medical claims payable, end of
period $5,788.0 $5,290.3 $4,853.4
Current year medical claims paid as
a percent of current year net
incurred medical claims 87.9% 88.0% 88.2%
Prior year redundancies in the
current period as a percent of prior
year net medical claims payable less
prior year redundancies in the
current period 6.8% 14.7% 18.7%
Prior year redundancies in the
current period as a
percent of prior year net
incurred medical claims -
as reported (2) 0.8% 1.9% 4.2%
Prior year redundancies in the
current period as a percent of prior
year net incurred medical claims -
adjusted for acquisitions (2) 0.8% 1.6% 2.1%
(1) Negative amounts reported for net incurred medical claims related to
prior years result from claims being settled for amounts less than
originally estimated.
(2) For all periods presented, except for the year ended December 31,
2007, the reported ratio of prior year redundancies in the current
period to prior year net incurred medical claims is impacted by
certain acquisitions (the former WellChoice, Inc. in 2005 and the
former WellPoint Health Networks Inc. in 2004). The Company has
provided ratios adjusted for these acquisitions in order to
demonstrate these impacts. Refer to the table entitled,
"Reconciliation of Medical Claims Payable - Adjusted Ratios" for
details regarding the respective calculation methodologies.
WellPoint, Inc.
Reconciliation of Medical Claims Payable - Adjusted Ratios
(Unaudited)
Note: Below are reconciliations for the adjusted ratios of prior year
redundancies in the current period to prior year net incurred medical
claims that are included in table entitled, "Reconciliation of Medical
Claims Payable."
Ratio for the Year Ended December 31, 2006
This ratio is impacted by having no net incurred medical claims for the
former WellChoice, Inc. ("WC") in 2005.
Net incurred medical claims related to prior
years (redundancies) - year ended December 31,
2006 (As Reported) $617.7
Net incurred medical claims - year ended
December 31, 2005 (As Reported) $32,865.6
Ratio (As Reported) 1.9%
Net incurred medical claims - year ended
December 31, 2005 (Comparable Basis)(1) $37,676.0
Ratio (As Adjusted) 1.6%
(1) Represents comparable benefit expense, assuming WC had been owned for
the entire year ended December 31, 2005.
Ratio for the Year Ended December 31, 2005
This ratio is impacted by having only one month of net incurred medical
claims for the former WellPoint Health Networks Inc. ("WHN") in 2004.
Net incurred medical claims related to prior
years (redundancies) - year ended December 31,
2005 (As Reported) $644.9
Net incurred medical claims - year ended
December 31, 2004 (As Reported) $15,344.9
Ratio (As Reported) 4.2%
Net incurred medical claims - year ended
December 31, 2004 (Comparable Basis) (2) $30,819.1
Ratio (As Adjusted) 2.1%
(2) Represents comparable benefit expense, assuming WHN had been owned for
the entire year ended December 31, 2004.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT
OF 1995
This document contains certain forward-looking information about
WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe
harbor for "forward-looking statements" provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements that
are not generally historical facts. Words such as "expect(s)", "feel(s)",
"believe(s)", "will", "may", "anticipate(s)", "intend", "estimate", "project"
and similar expressions are intended to identify forward-looking statements.
These statements include, but are not limited to, financial projections and
estimates and their underlying assumptions; statements regarding plans,
objectives and expectations with respect to future operations, products and
services; and statements regarding future performance. Such statements are
subject to certain risks and uncertainties, many of which are difficult to
predict and generally beyond the control of WellPoint, that could cause actual
results to differ materially from those expressed in, or implied or projected
by, the forward-looking information and statements. These risks and
uncertainties include: those discussed and identified in public filings with
the U.S. Securities and Exchange Commission ("SEC") made by WellPoint;
increased government regulation of health benefits, managed care and pharmacy
benefit management operations; trends in health care costs and utilization
rates; our ability to secure sufficient premium rate increases; our ability to
contract with providers consistent with past practice; competitor pricing
below market trends of increasing costs; reduced enrollment, as well as a
negative change in our health care product mix; risks and uncertainties
regarding the Medicare Part D Prescription Drug benefits program, including
potential uncollectability of receivables resulting from processing and/or
verifying enrollment (including facilitated enrollment), inadequacy of
underwriting assumptions, inability to receive and process information,
uncollectability of premium from members, increased pharmaceutical costs, and
the underlying seasonality of the business; a downgrade in our financial
strength ratings; litigation and investigations targeted at health benefits
companies and our ability to resolve litigation and investigations within
estimates; our ability to meet expectations regarding repurchases of shares of
our common stock; funding risks with respect to revenue received from
participation in Medicare and Medicaid programs; non-compliance with the
complex regulations imposed on Medicare and Medicaid programs; events that
result in negative publicity for the health benefits industry; failure to
effectively maintain and modernize our information systems and e-business
organization and to maintain good relationships with third party vendors for
information system resources; events that may negatively affect our license
with the Blue Cross and Blue Shield Association; possible impairment of the
value of our intangible assets if future results do not adequately support
goodwill and other intangible assets; intense competition to attract and
retain employees; unauthorized disclosure of member sensitive or confidential
information; changes in the economic and market conditions, as well as
regulations, applicable to our investment portfolios; possible restrictions in
the payment of dividends by our subsidiaries and increases in required minimum
levels of capital and the potential negative affect from our substantial
amount of outstanding indebtedness; general risks associated with mergers and
acquisitions; various laws and our governing documents may prevent or
discourage takeovers and business combinations; potential hedging activities
in our common stock; future bio-terrorist activity or other potential public
health epidemics; and general economic downturns. Readers are cautioned not to
place undue reliance on these forward-looking statements that speak only as of
the date hereof. Except to the extent otherwise required by federal
securities law, WellPoint does not undertake any obligation to republish
revised forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated events. Readers
are also urged to carefully review and consider the various disclosures in
WellPoint's SEC reports.
SOURCE WellPoint, Inc.